Medication-info.com Search Menu

Budesonide Extended-Release: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
9 mg
Drug class:
Active ingredient:

Patient information: uses, side effects, how to take - Budesonide Extended-Release

What are budesonide extended-release tablets?

  • Budesonide extended-release tablets are a prescription corticosteroid medicine used to help get active mild to moderate ulcerative colitis (UC) under control (induce remission).
  • It is not known if budesonide extended-release tablets are safe and effective in children.

Who should not take budesonide extended-release tablets?

Do not take budesonide extended-release tablets if:

  • you are allergic to budesonide or any of the ingredients in budesonide extended-release tablets. See the end of this leaflet for a complete list of ingredients in budesonide extended-release tablets.

What should I tell my healthcare provider before taking budesonide extended-release tablets?

Before you take budesonide extended-release tablets tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems.
  • are planning to have surgery.
  • have chickenpox or measles or have recently been near anyone with chickenpox or measles.
  • have an infection, including fungal and threadworm (Strongyloides) infections.
  • have or had a family history of diabetes, cataracts or glaucoma.
  • have or had tuberculosis.
  • have high blood pressure (hypertension).
  • have decreased bone mineral density (osteoporosis).
  • have stomach ulcers.
  • have malaria of the brain (cerebral malaria).
  • are pregnant or plan to become pregnant. Budesonide extended-release tablets may harm your unborn baby. Tell your healthcare provider if you are pregnant or think you are pregnant.

  • are breastfeeding or plan to breastfeed. Budesonide can pass into your breast milk and may harm your baby. You and your healthcare provider should decide if you will take budesonide extended-release tablets or breastfeed. You should not do both.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Budesonide extended-release tablets and other medicines may affect each other causing side effects.

Especially tell your healthcare provider if you take another medicine that contains corticosteroids for other conditions, such as allergies or asthma. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

How should I take budesonide extended-release tablets?

  • Take budesonide extended-release tablets exactly as your healthcare provider tells you to take them.
  • Take budesonide extended-release tablets 1 time each day in the morning with or without food.

  • Take budesonide extended-release tablets whole with water. Do not chew, crush, or break budesonide extended-release tablets before swallowing.
  • If you take too many budesonide extended-release tablets, call your healthcare provider right away or go to the nearest hospital emergency room.

What should I avoid while taking budesonide extended-release tablets?

  • Do not eat grapefruit or drink grapefruit juice while taking budesonide extended-release tablets. Eating grapefruit or drinking grapefruit juice can increase the level of budesonide in your blood.

What are the possible side effects of budesonide extended-release tablets?

Budesonide extended-release tablets may cause serious side effects, including:

  • Effects of having too much corticosteroid medicine in your blood (hypercorticism). Long-time use of budesonide extended-release tablets can cause you to have too much glucocorticosteroid medicine in your blood. Tell your healthcare provider if you have any of the following signs and symptoms of hypercorticism:

    • acne
    • bruise easily
    • rounding of your face (moon face)
    • ankle swelling
    • thicker or more hair on your body and face
    • a fatty pad or hump between your shoulders (buffalo hump)
    • pink or purple stretch marks on the skin of your abdomen, thighs, breasts and arms
  • Adrenal suppression. When budesonide extended-release tablets are taken for a long period of time (chronic use), the adrenal glands do not make enough steroid hormones (adrenal suppression).

    Tell your healthcare provider if you are under stress or have any symptoms of adrenal suppression during treatment with budesonide extended-release tablets including:

  • tiredness
  • weakness
  • nausea
  • vomiting
  • low blood pressure
  • Decreased ability of your body to fight infections (immunosuppression) and increased risk of infection.

    Corticosteroid medicines, including budesonide extended-release tablets, lower the ability of your immune system to fight infections and increase the risk of infections caused by viruses, bacteria, fungi, protozoan, or certain parasites. Corticosteroid medicines, including budesonide extended-release tablets, can also:

    • make current infections worse
    • increase the risk of infections spreading (disseminated)
    • increase the risk of making infections active again or making infections worse that have not been active (latent)
    • hide (mask) some signs of infection

These infections can be mild but can be severe and lead to death. Your healthcare provider should check you closely for signs and symptoms of an infection while taking budesonide extended-release tablets. Tell you healthcare provider right away about any signs or symptoms of a new or worsening infection while taking budesonide extended-release tablets, including flu-like symptoms such as:

  • fever
  • chills
  • stomach area (abdominal)

    pain

  • aches
  • diarrhea
  • cough
  • pain
  • feeling tired
  • nausea and vomiting
    • Tuberculosis: If you have inactive (latent) tuberculosis, your tuberculosis may become active again while taking budesonide extended-release tablets. Your healthcare provider should check you closely for signs and symptoms of tuberculosis while taking budesonide extended-release tablets.
    • Chickenpox and measles: People taking corticosteroid medicines, including budesonide extended-release tablets, who have not had chickenpox or measles, should avoid contact with people who have these diseases. Tell your healthcare provider right away if you come in contact with anyone who has chickenpox or measles.
    • Hepatitis B virus (HBV) reactivation: If you are a carrier of HBV, the virus can become an active infection again while taking budesonide extended-release tablets. Your healthcare provider will test you for HBV before you start taking budesonide extended-release tablets.
    • Amebiasis: Inactive (latent) amebiasis may become an active infection while taking budesonide extended-release tablets. Your healthcare provider should check you for amebiasis before you start taking budesonide extended-release tablets in people who have spent time in the tropics or have unexplained diarrhea.
  • Kaposi’s sarcoma. Kaposi’s sarcoma has happened in people who received corticosteroid therapy, most often for treatment of long-lasting (chronic) conditions.
  • Worsening of allergies. If you take certain other corticosteroid medicines to treat allergies, switching to budesonide extended-release tablets may cause your allergies to come back. These allergies may include eczema (a skin disease) or rhinitis (inflammation inside your nose). Tell your healthcare provider if any of your allergies become worse while taking budesonide extended-release tablets.

The most common side effects of budesonide extended-release tablets include:

  • headache
  • nausea
  • decreased blood
  • cortisol levels
  • stomach-area pain
  • tiredness
  • stomach or intestinal gas
  • bloating
  • acne
  • urinary tract infection
  • joint pain
  • constipation

Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

These are not all the possible side effects of budesonide extended-release tablets. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store budesonide extended-release tablets?

  • Store budesonide extended-release tablets at room temperature, between 20° to 25°C (68° to 77°F).
  • Keep the bottle tightly closed to protect budesonide extended-release tablets from light and moisture.

Keep budesonide extended-release tablets and all medicines out of the reach of children.

General information about the safe and effective use of budesonide extended-release tablets.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use budesonide extended-release tablets for a condition for which they were not prescribed. Do not give budesonide extended-release tablets to other people, even if they have the same symptoms you have. They may harm them.

You can ask your healthcare provider or pharmacist for information about budesonide extended-release tablets that is written for health professionals.

For more information, call Mylan at 1-877-446-3679 (1-877-4-INFO-RX).

What are the ingredients in budesonide extended-release tablets?

Active ingredient: budesonide

Inactive ingredients: colloidal silicon dioxide, hydroxypropyl cellulose, hypromellose, lactose monohydrate, magnesium stearate, methacrylic acid copolymer type A and type B, microcrystalline cellulose, polyethylene glycol, polydextrose, talc, titanium dioxide, triacetin and triethyl citrate.

In addition, the black imprinting ink contains black iron oxide, hypromellose and propylene glycol.

Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

This Patient Information has been approved by the U.S. Food and Drug Administration.

Manufactured for:

Mylan Pharmaceuticals Inc.

Morgantown, WV 26505 U.S.A.

Manufactured by:

ALPHAPHARM PTY LTD

15 Garnet Street

Carole Park QLD 4300

Australia

Revised: 11/2024

ALP:BUDEERT:R3

(3491/2)

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: ANDA 208851 · View the label on DailyMed

Revision date stated in the text: November 2024

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Budesonide Extended-Release

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Drug class Corticosteroid
Active ingredient Budesonide 9 mg
Dosage form Tablet, film coated, extended release
Route Oral
Marketing status listed in the FDA NDC Directory
Company (applicant) MYLAN
FDA approval ANDA 208851Abbreviated New Drug Application (ANDA) – generic drug Approved September 17, 2020
Therapeutic equivalence (TE) code ABCodes starting with A mean the FDA rates the drug therapeutically equivalent to its reference drug (Orange Book).
Manufacturers 3 labelers list this drug on DailyMed
Packages (NDC)
Package
9 mg – 30 in 1 bottle, plastic NDC 0378-4500-93

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.